|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Fahrmann, Johannes F.; Saini, Neeraj Y.; Chia-Chi, Chang; Irajizad, Ehsan; Strati, Paolo; Nair, Ranjit; Fayad, Luis E.; Ahmed, Sairah; Lee, Hun Ju; Iyer, Swaminathan; Steiner, Raphael; Vykoukal, Jody; Wu, Ranran; Dennison, Jennifer B.; Nastoupil, Loretta; Jain, Preetesh; Wang, Michael; Green, Michael; Westin, Jason; Blumenberg, Viktoria; Davila, Marco; Champlin, Richard; Shpall, Elizabeth J.; Kebriaei, Partow; Flowers, Christopher R.; Jain, Michael; Jenq, Robert; Stein-Thoeringer, Christoph K.; Subklewe, Marion; Neelapu, Sattva S. und Hanash, Sam
(2022):
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in B cell lymphoma.
In: Cell Reports Medicine, Bd. 3, Nr. 11, 100720
2020
Dreyling, Martin; Tam, Constantine S.; Wang, Michael; Smith, Stephen D.; Ladetto, Marco; Huang, Huiqiang; Novotny, William; Co, Melannie; Romano, Alfredo; Holmgren, Eric; Huang, Jane und Le Gouill, Steven
(2020):
A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma.
In: Future Oncology, Bd. 17, Nr. 03: S. 255-262
2017
Rule, Simon; Dreyling, Martin; Goy, Andre; Hess, Georg; Auer, Rebecca; Kahl, Brad; Cavazos, Nora; Liu, Black; Yang, Shiyi; Clow, Fong; Goldberg, Jenna D.; Beaupre, Darrin; Vermeulen, Jessica; Wildgust, Mark und Wang, Michael
(2017):
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.
In: British Journal of Haematology, Bd. 179, Nr. 3: S. 430-438